Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+ 

March 31, 2020  |  Startland News Staff

A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.

The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.

“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”

Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.

Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.

Solus Gold Embolization Device

The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.

The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.

Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.

Click here to learn more about these peripheral vascular solutions.

“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”

Tagged , , , ,
Featured Business
    Featured Founder
      [adinserter block="4"]

      2020 Startups to Watch

        stats here

        Related Posts on Startland News

        Report: Tech drives nearly a 10th of Kansas City’s economy (and those employers are hiring)

        By Tommy Felts | October 6, 2025

        Advocates tout KC for top-tier tech talent; a new report affirms its status as an emerging market with potential for big impact A combination of economic stability, depth and skill of talent, and operational efficiency creates conditions for companies to grow and succeed in Kansas City, said Kara Lowe, detailing new data that suggests the…

        InvestMidwest back in KC ahead of World Cup rush; four new leaders join board roster

        By Tommy Felts | October 6, 2025

        A powerhouse quartet of venture experts are on board for the next wave of InvestMidwest impact, said Claire Kinlaw, announcing plans for the two-day summit’s bounce back to Kansas City this spring as organizers push to boost deal flow in a region outside the startup-dense coasts. New to InvestMidwest’s board as planning gets under way…

        Fan favorite vote: AltCap Your Biz launches crowd-sourced contest as pitch event nears

        By Tommy Felts | October 3, 2025

        One of 10 finalists in a popular fall pitch event for small businesses is expected to win $5,000 based solely on community votes, leaders at AltCap announced Friday, launching this year’s voting portal ahead of mid-November competition at Union Station. “The Fan Favorite Contest invites the community to discover amazing local businesses, to learn about…